The current study presents the synthesis of thiophene-appended pyrazoles through 3+2 annulations of chalcones 3(a-g) with aryl hydrazine hydrochlorides 4(a-d) in acetic acid (30%) under reflux conditions produced the thiophene-pyrazole hybrids 5(a-g) in good yields. Structures of synthesized new pyrazoles were confirmed by spectral studies, and elemental analysis. Further, preliminary biological evaluation studies show that compounds 5b and 5f having chloro substitution only in the thiophene ring exhibited excellent inhibition (12.5-25.0 µg/mL) against all the tested organisms in comparison with that of the standard. Compounds, 5a, 5c and 5g having electronegative chloro substitutions each in the aromatic and thiophene rings showed excellent (12.423-31.213 µg mL -1 ) DPPH radical scavenging potencies. The synthesis of pyrazoline derivatives and the efficacy of some of the synthesized molecules as antimicrobial and antioxidant agents validate the significance of this study.
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Introduction
An interest in discovery, design and synthesis of novel small-molecules with antimicrobial and radical scavenging effects is propelling research in the wider research community in order to prevent the deleterious effects that free-oxide radicals can inflict upon the human body. Duloxetine is a "blockbuster" antidepressant without any adverse effect associated with the formation of RMs due to the judicious conjugation of thiophene moiety with naphthalene, 1 which facilitates the potentiality of employing this functional group for the synthesis of small-molecules with desired biological effect. Chalcones are the principal precursors for the synthesis of bioactive small molecules such as benzothiazepines, 2 pyrazolines, 3 isoxazolines, 4 cylopropanes, 5 oxadiazoles, 6 etc., The chalcones are most commonly synthesized via Claisen-Schmidt reaction of an aromatic aldehyde with acetophenones. 7 Chalcones has gained importance due to their simple structures and diverse pharmacological applications. 8 Design and synthesis of simple heterocycles with various bioactivities is a worthwhile contribution in organic synthesis. The compounds with pyrazole core are the most important class in active pharmaceutical drugs and remain the choice for anti-inflammatory agents in spite of multiple attempts at exploring alternative scaffolds. 9, 10 Amongst the various methods available in the literature for the synthesis of pyrazole scaffolds, most commonly employed being; a base catalyzed reaction of hydrazines with 1,3-dicarbonyl compounds, 11 1,3-dipolar cycloaddition of hydrazones to alkenes, 12 and via Vilsmeier-Haack reaction of arylhydrazones. 13 Further, it is emphasized here that pyrazoles are regarded as promising molecules with potential applications in bioorganic chemistry. Pyrazoles were known to exhibit anticancer, 14 antimicrobial, 15 anesthetic, 16 antioxidant, 17 and analgesic 18 activities. In view of the wide range of synthetic and biological applications of pyrazoles, we herein report the synthesis of derivatives of pyrazoles and the results of their in vitro evaluation for antimicrobial and DPPH radical scavenging activities. The demonstrated synthesis paves the way for future efforts at synthesizing pyrazoles that could find widespread applications in medicinal chemistry.
Results and Discussion

Chemistry
Initially, the intermediate 3-aryl-1-(5-chlorothiophen-2-yl)prop-2-en-1-ones, 3(a-d), were synthesized by base catalyzed reaction of 2-acetyl-5-chlorothiophene, 1, with aromatic aldehydes, 2(ad) in methyl alcohol. Then, the reaction of 3(a-d) and arylhydrazine hydrochloride 4(a-b) in aqueous acetic acid under reflux conditions produced pyrazole derivatives 5(a-g) (Fig. 1) . 1 H NMR, 13 C NMR, MS and elemental analysis provided the structural proof for the compounds, 3(a-d) and 5(a-g). All designed series of compounds, 3(a-d) and 5(a-g) showed a base peak corresponding to their molecular masses and also 37 Cl, 81 Br isotope peaks. Further, all compounds showed satisfactory elemental analyses compared with theoretical values, which strongly favour the formation of the designed products.
Biological evaluations
Antimicrobial activity
The new synthesized pyrazole derivatives 5(a-g) were screened for their antibacterial and antifungal activity by serial dilution method. 19 The experiments were carried out in triplicate; the results were taken as a mean of three determinations (n=3). For antibacterial studies, the bacteria species Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa; for antifungal studies, Aspergillus niger, Aspergillus flavus and Candila albicans were used as microbial strains. The antibiotics ciprofloxacin and nystatin were used as reference drugs against bacteria and fungi species respectively. The results of MIC's of the synthesized compounds against bacteria and fungi species were summarized in Table 1 respectively.
Preliminary studies reveal that the synthesized series of new pyrazole derivatives 5(a-g) showed broad spectrum of antimicrobial activities against the tested species. Amongst the series, compounds 5b and 5f having chloro substitution only in the thiophene ring exhibited excellent inhibition (12.5-25.0 µg/mL) against all the tested organisms in comparison with that of the standard. Promising inhibition was shown by compound 5a against C. albicans (25.0 µg/mL), and 5c against P. aeruginosa (12.5 µg/mL). Compounds 5d and 5e having bromo substitutions in the aromatic ring showed poorer inhibition (50.0-100.0 µg/mL) against the tested species. Compound 5c showed moderate inhibition against S. aureus (75.0 µg/mL), A. niger (100.0 µg/mL), and A. flavus (100.0 µg/mL); and 5c against A. flavus (100.0 µg/mL), and C. albicans (75.0 µg/mL), and 5c against S. aureus (75 µg/mL) and E. coli (75.0 µg/mL) species. Moderate inhibition showed by compounds, 5a against E. coli (37.5 µg/mL) and P. aeruginosa (25.0 µg/mL); 5c against S. aureus (37.5 µg/mL), E. coli (37.5 µg/mL), and A. niger (75.0 µg/mL); and 5g against P. aeruginosa (25.0 µg/mL), and A. niger (100.0 µg/mL) organisms. 
DPPH radical scavenging activity
The DPPH radical scavenging ability of the synthesized compounds 5(a-g) was performed by a reported procedure. 21 The experiments were performed with different aliquots of test samples (25, 50, 75 and 100 μg mL -1 ) in methanol and the absorbance was read against blank at 517nm in an ELICO SL 159 UV visible spectrophotometer. Tests were carried out in triplicate and the results are expressed as I% ± standard deviations and were summarized in Table 2 .
Preliminary studies of synthesized pyrazoline derivatives moderate to good DPPH radical scavenging abilities because of their H-donating capacity. Results of the investigations shows that the compounds 5d and 5e were having bromo substitutions in the aromatic rings showed moderate (28.500-55.900 µg mL -1 ). Compounds, 5a, 5c and 5g having electronegative chloro substitutions each in the aromatic and thiophene rings showed excellent (12.423-31.213 µg mL 
Conclusions
The synthesis of pyrazoline derivatives and the efficacy of some of the synthesized molecules as antimicrobial and antioxidant agents validate the significance of this study. Preliminary studies show that compounds 5b and 5f having chloro substitution only in the thiophene ring exhibited significant excellent inhibition (12.5-25.0 µg/mL) against all the tested organisms in comparison with that of the standard. Compounds, 5a, 5c and 5g having electronegative chloro substitutions each in the aromatic and thiophene rings showed excellent (12.423-31.213 µg mL -1 ) DPPH radical scavenging potencies.
Experimental
Materials and Methods
Melting points were determined by an open capillary tube method and are uncorrected. 
General procedure for synthesis of chalcones, 3(a-d):
To a solution mixture of 5-chloro-2-acetylthiophene, 1 (10 mmol) and aromatic aldehydes, 2(a-d) (10 mmol) in methyl alcohol, potassium hydroxide solution (40%, 2 mL) was added. Then the solution mixture was stirred at room temperature for 3-4 h. The progress of the reaction was monitored by TLC. After the completion, the reaction mixture was cooled to room temperature and poured into ice cold water. Solids separated were filtered, washed successively with cold hydrochloric acid (5%) and cold water. Crude solids were recrystallized from methyl alcohol to obtain the compounds 3(a-d).
General procedure for synthesis of pyrazoles, 5(a-g):
A solution mixture of chalcones, 3(a-d) (10 mmol) and phenylhydrazine hydrochlorides, 4(a-b) (10 mmol) in aqueous acetic acid (30%) was refluxed for 2-3 h. The progress of the reaction was monitored by TLC. After the completion, the mixture was cooled and poured in to a crushed ice. The separated solids were filtered and washed with water. Crude solids were recrystallized from ethyl alcohol to get target molecules 5(a-g).
Physical and Spectral Data
1-(5-Chlorothiophen-2-yl)-3-(4-(dimethylamino)phenyl)prop-2-en-1-one, 3a:
We have reported the synthesis and characterization earlier. 23 
1-(5-Chlorothiophen-2-yl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one, 3b:
Obtained from 2-acetyl-5-chlorothiophene, 1 (1.69g, 10 mmol) and 3,4-dimethoxybenzaldehyde, 2b (1.66g, 10 mmol) in 78% yield; m.p. 122-125 °C. 
3-(4-Bromophenyl)-1-(5-chlorothiophen-2-yl)prop-2-en-1-one, 3c:
Obtained from 2-acetyl-5-chlorothiophene, 1 (1.69g, 10 mmol) and 4-bromobenzaldehyde, 2c (1.84g, 10 mmol) in 66% yield; m.p. 116-118 °C. Chlorothiophen-2-yl)-3-(2,4-dimethylphenyl)prop-2-en-1-one, 3d: Obtained from 2-acetyl-5-chlorothiophene, 1 (1.69g, 10 mmol) and 2,4-dimethylbenzaldehyde, 2d (1.34g, 10 (1-(3-Chlorophenyl)-3-(5-chlorothiophen-2-yl)-4,5-dihydro-1H-pyrazol-5-yl)-N,Ndimethylaniline, 5a: Obtained from 1-(5-chlorothiophen-2-yl)-3-(4-(dimethylamino)phenyl)prop-2-en-1-one, 3a (1.49g, 10 mmol) and (3-chlorophenyl)hydrazine hydrochloride, 4b (1.78g, 10 
1-(5-
4-
5-(4-Bromophenyl)-3-(5-chlorothiophen-2-yl)-1-phenyl-4,5-dihydro-1H-pyrazole,
5d: Obtained from 3-(4-bromophenyl)-1-(5-chlorothiophen-2-yl)prop-2-en-1-one, 3c (3.25g, 10 mmol) and phenylhydrazine hydrochloride, 4a ( Bromophenyl)-1-(3-chlorophenyl)-3-(5-chlorothiophen-2-yl)-4,5-dihydro-1H-pyrazole,  5e: Obtained from 3-(4-bromophenyl)-1-(5-chlorothiophen-2-yl)prop-2-en-1-one, 3c (3.25g, 10 
5-(4-
1-(3-Chlorophenyl)-3-(5-chlorothiophen-2-yl)-5-(2,4-dimethylphenyl)-4,5-dihydro-1H-
